**Core tip:** Anaplastic large cell lymphoma (ALCL) encompasses two distinct categories: anaplastic lymphoma kinase-positive (ALK+) and ALK-negative. ALK+ ALCL cases rarely involve the gut. However, in a very small number of case reports, gastrointestinal ALK+ ALCL exhibits a fungating growth pattern, similar to that of B-cell lymphomas rather than T-cell lymphomas. Multiple lymphomatous polyposis (MLP) is thought to be a typical form of gastrointestinal lesion in mantle cell lymphoma, but it develops in other B-cell lymphomas. T-cell lymphomas seldom present with MLP. Here, we report the first known case in the world of ALK+ ALCL with gastroduodenal involvement presenting with MLP.

INTRODUCTION
============

Anaplastic large cell lymphoma (ALCL) was first described in 1985 by Stein et al\[[@B1]\]. According to the 4^th^ edition (2008) of the WHO classification\[[@B2]\], primary systemic ALCL can be divided into two distinct categories: anaplastic lymphoma kinase-positive (ALK+) and ALK-negative. Majority of ALK+ ALCL contain a t(2;5) chromosomal translocation. The t(2;5) translocation fuses a distal part of the *ALK* gene on chromosome 2p23 with the promoter and a proximal domain of the nucleophosmin (*NPM1*) gene on chromosome 5q35\[[@B3]\]. The most common extranodal sites of ALK+ ALCL are the skin, bone and soft tissue. ALK+ ALCL cases involving the gut are rare\[[@B2]\].

Multiple lymphomatous polyposis (MLP) is thought to be a representative form of gastrointestinal lesion in mantle cell lymphoma (MCL)\[[@B2],[@B4],[@B5]\]. Here, we report an extremely rare case of ALK+ ALCL with gastroduodenal involvement presenting as MLP.

CASE PRESENTATION
=================

Chief complaints
----------------

A 43-year-old Japanese man suffering from fever, night sweats, general fatigue and weight loss complained of a mass in the left inguinal area. The patient did not complain of gastrointestinal symptoms.

History of present illness
--------------------------

The patient was admitted to a local hospital. Computed tomography (CT) scan demonstrated multiple lymph node lesions continuing to the mesentery and para-aortic/left common iliac artery/left inguinal region (Figure [1](#F1){ref-type="fig"}). Scattered nodular lesions were found in both lung fields (Figure [1](#F1){ref-type="fig"}). Following needle biopsy of the left inguinal lesion, malignant lymphoma was suspected, and the patient was transferred to our department.

![Computed tomography images. (Upper row) Pelvic computed tomography scan demonstrated multiple lymph node lesions (arrows) continuing to the left common iliac artery (left)/left inguinal region (right). (Lower row) Scattered nodular lesions were found in both lung fields (arrows).](WJCC-7-2049-g001){#F1}

History of past illness
-----------------------

He had no chronic illness.

Physical examination upon admission
-----------------------------------

Left inguinal lymph nodes were significantly swollen.

Laboratory examinations
-----------------------

WBC and CRP showed markedly high values, and elevated platelet count, liver dysfunction, and hypoalbuminemia were also observed. In addition, the level of soluble interleukin-2 receptor (normal range: 121-613 U/mL), which was severely elevated according to the measurement of the previous hospital, had further increased over approximately one week (7120 → 12500 U/mL) (Table [1](#T1){ref-type="table"}).

###### 

Results of laboratory examinations on admission

  ----- ----------------- --------- -------------
  WBC   21.5 × 10^9^/L    TP        5.8 g/dL
  St    3%                Alb       2.3 g/dL
  Seg   73%               GOT       117 IU/L
  Lym   16%               GPT       252 IU/L
  Mon   4%                LDH       275 IU/L
  Eos   4%                ALP       753 IU/L
  RBC   3.99 × 10^12^/L   γ-GTP     170 IU/L
  Hb    12.1 g/dL         T-Bil     0.2 mg/dL
  Hct   36.3%             CRP       13.00 mg/dL
  Plt   695 × 10^9^/L     s-IL-2R   12500 U/mL
  ----- ----------------- --------- -------------

St: Stab; Seg: Segmented; Lym: Lymphocytes; Mon: Monocytes; Eos: Eosinophil; Hb: Hemoglobin; Hct: Hematocrit; TP: Total protein; sIL-2R: Soluble interleukin-2 receptor.

Imaging examinations
--------------------

As measured by positron emission tomography (PET)/CT scan, the mean standardized uptake value was 18.1 in the abdomen -- pelvis/inguinal nodes and 3.5 in the lung fields and the mediastinal nodes (Figure [2](#F2){ref-type="fig"}).

![Positron emission tomography/computed tomography (longitudinal) image. Arrows indicate lymphoma lesions. The mean of the standardized uptake value was 18.1 in the multiple lymph node lesions continuing to the mesentery and para-aortic/left common iliac artery/left inguinal, 3.5 in the lesions of the lung fields and the mediastinal nodes. No uptake in the stomach and duodenum.](WJCC-7-2049-g002){#F2}

**Esophagogastroduodenoscopy findings**: In the descending portion of the duodenum, multiple polypoid lesions of 2-3 mm in diameter were observed (Figure [3A](#F3){ref-type="fig"}). Various large and small polypoid lesions were observed in the antrum of the stomach (Figure [3B](#F3){ref-type="fig"} and Figure [3C](#F3){ref-type="fig"}). These lesions are consistent with MLP continuously extending from the antrum of the stomach to the descending portion of the duodenum. Mucosal folds in the corpus of the stomach were slightly thickened, and its surface had changed to a white tone (Figure [3D](#F3){ref-type="fig"}).

![Esophagogastroduodenoscopy findings. Multiple polypoid lesions of 2-3 mm in diameter were seen in the descending portion of the duodenum (A). Various large and small polypoid lesions were seen in the antrum of the stomach (B; lesser curvature side, C; extensive curvature side), accompanied by a change in white tone at the center. Mucosal folds in the corpus of the stomach at the extensive curvature side were slightly thickened, and its surface had changed to a white tone (D). After treatment, numerous white scars were found, and the thickened mucosal folds were improved in the stomach (E).](WJCC-7-2049-g003){#F3}

The biopsies of both gastric and duodenal lesions proved the invasion of lymphoma cells, as below mentioned. These lesions could not be detected by PET/CT scan. Colonoscopy and bone marrow aspiration showed no involvement of lymphoma lesions.

Pathological examinations
-------------------------

Left inguinal lymph nodes were examined by open biopsy. Medium to large-sized abnormal lymphoid cells were observed to be invasively proliferating. CD25, CD30, T-cell intracellular antigen-1, and ALK tested positive by immunostaining. Meanwhile, CD3, CD20 and the Epstein-Barr encoding region *in situ* hybridization tested negative. Based on the histopathology, ALK+ ALCL was diagnosed. In the gastric and duodenal biopsy samples, abnormal lymphoid cells with irregular nuclei grew diffusely (Figure [4A](#F4){ref-type="fig"}), and mitotic figures were observed in high numbers (Figure [4B](#F4){ref-type="fig"}). Immunohistochemically, CD30 tested strongly positive (Figure [4C](#F4){ref-type="fig"}), ALK (monoclonal antibody, ALK1) tested positive in nuclear and cytoplasmic pattern (Figure [4D](#F4){ref-type="fig"}), and the Ki-67 proliferative (MIB1) index was \> 80% (not shown).

![Histopathological findings in biopsy samples (x 200), Medium to large-sized abnormal lymphoid cells with irregular nuclei grew diffusely (A), and mitotic figures were observed in high numbers (B). In immunostaining of lymphoma cells, CD30 was strongly positive (C), and ALK showed positive in nuclear and cytoplasmic patterns (D).](WJCC-7-2049-g004){#F4}

FINAL DIAGNOSIS
===============

ALK+ ALCL that involved multiple lymph node lesions in the abdomen - pelvis/inguinal region and mediastinum, also both lung fields and the gastroduodenal lesions (Stage IV).

TREATMENT
=========

We treated this patient with six cycles of CHOEP chemotherapy (Cyclophosphamide 750 mg/m^2^, Doxorubicin 50 mg/m^2^, Vincristine 1.4 mg/m^2^, Etoposide 100 mg/m^2^ x 3 d, and Prednisone 50 mg/m^2^ x 5 d) every three weeks. After administration of two cycles, the lymphoma lesions including lung field nodules shrank remarkably and disappeared at CT examination.

OUTCOME AND FOLLOW-UP
=====================

At the conclusion of treatment, there was complete remission. Numerous white scars were found in the stomach, endoscopically consistent with a remission image of lymphoma (Figure [3E](#F3){ref-type="fig"}). He is followed-up as outpatient with no treatment. There was no evidence of recurrence for more than 1 year and 10 mo since the end of the final treatment.

DISCUSSION
==========

ALCL is a clinically, morphologically, and immunophenotypically heterogeneous T-cell lymphoma. Depending on the presence or absence of ALK expression, ALK+ ALCL was classified as a biologically homogeneous disease unit independent of ALK-negative ALCL in the 4th edition (2008) of the WHO classification\[[@B2]\]. ALK+ ALCL is more prevalent in children and young adults, and the ALK fusion protein is associated with a good prognosis\[[@B6]\]. In contrast, ALK-negative ALCL has a poor prognosis similar to peripheral T-cell lymphoma, not otherwise specified, and angioimmunoblastic T-cell lymphoma\[[@B7]\]. ALK staining pattern is nuclear and cytoplasmic in cases of t(2;5)/NPM-ALK translocation, and membranous or diffuse/granular cytoplasmic in the remaining cases with a variant translocation involving at 2p23\[[@B2],[@B8]\]. ALK staining in our patient showed a nuclear and cytoplasmic pattern. G-banded karyotype of the lymph node lesions showed complex chromosomal abnormalities with +2, der(2;21)(q10;q10),+7, however, translocation at 2p23 could not be confirmed. ALK+ ALCL frequently involves both lymph nodes and extranodal sites. The most commonly involved extranodal sites include the skin, bone, soft tissue, liver and lungs as we reported here\[[@B2]\].

Because gastrointestinal T-cell lymphomas are rare, little is known about the clinicopathological characteristics of primary gastrointestinal T-cell lymphomas. Kim et al\[[@B9]\] investigated the endoscopic differences between B- and T-cell lymphomas and observed that B-cell lymphomas presented more often as fungating (54% of cases), while T-cell lymphomas were frequently ulcerative (47%), and only 13% showing a fungating pattern. Regardless of ALK expression, primary gastrointestinal ALCL is rarer\[[@B10]\]. According to a recent review on gastrointestinal ALCL, the rate of ALK expression among gastrointestinal ALCL was low at 24%\[[@B11]\]. As far as we can determine, ALK+ ALCL of the gut has been reported in only eleven cases\[[@B11]-[@B20]\]. The clinical features are summarized in Table [2](#T2){ref-type="table"} for a total of 12 gastrointestinal ALK+ ALCL cases, including our patient. Of these, four cases were reported to involve the esophagus\[[@B12]-[@B15]\], all showing fungating tumors. Of the remaining cases, two involved the stomach\[[@B11],[@B16]\], one involved the duodenum\[[@B17]\], one involved both the stomach and duodenum\[[@B18]\], and three involved the small intestine (jejunum/ileum)\[[@B11],[@B19],[@B20]\]. Only three of these last seven cases showed macroscopic findings by resection or endoscopy; the morphology showed a mass formation pattern, such as a submucosal or bulky tumor. Although the number of cases is very small, gastrointestinal ALK+ ALCL often seems to involve the esophagus, in which lymphomas rarely develop, and frequently exhibits a fungating growth pattern similar to that of B-cell lymphomas.

###### 

Clinical features of gastrointestinal anaplastic lymphoma kinase-positive anaplastic large cell lymphoma

  **Case**   **Age / sex**   **Ref**.     **Occurrence site**        **Gross** **/ Endoscopic findings**   **ALK staining pattern**   **2p23** **(FISH /** **RT-PCR)**   **Treatment**        **Outcome**
  ---------- --------------- ------------ -------------------------- ------------------------------------- -------------------------- ---------------------------------- -------------------- ---------------
  1          56/M            \[[@B12]\]   Esophagus                  Large mass                            Cytoplasmic                                                   chemo. + auto-SCT    Alive (3 mo)
  2          34/F            \[[@B13]\]   Esophagus                  Fungating tumor                       Nuclear and cytoplasmic                                       chemo. + auto-SCT    Alive (24 mo)
  3          37/M            \[[@B14]\]   Esophagus                  Submucosal mass                       Nuclear and cytoplasmic                                       resection + chemo.   Alive (14 mo)
  4          3/M             \[[@B15]\]   Esophagus                  Wall thickening                       Nuclear and cytoplasmic                                       chemo.               (undescribed)
  5          53/M            \[[@B11]\]   Stomach                    (Undescribed)                         Cytoplasmic                                                   resection + chemo.   Alive (84 mo)
  6          72/F            \[[@B16]\]   Stomach                    (Undescribed)                         (Undescribed)              \+ (FISH)                          resection            Alive (84 mo)
  7          36/M            \[[@B17]\]   Duodenum                   (Undescribed)                         Nuclear and cytoplasmic    \+ (RT-PCR)                        resection + chemo.   Alive (24 mo)
  8          21/M            \[[@B18]\]   Stomach and Duodenum       Submucosal tumor                      Nuclear and cytoplasmic                                       chemo.               (undescribed)
  9          10/M            \[[@B11]\]   Small intestine            (Undescribed)                         Nuclear and cytoplasmic                                       resection + chemo.   Alive (75 mo)
  10         17/M            \[[@B19]\]   Jejunum                    Polypoidal mass                       Cytoplasmic                                                   resection + chemo.   Alive (18 mo)
  11         32/M            \[[@B20]\]   Jejunum/Ileum (junction)   Massive tumor                         Nuclear and cytoplasmic                                       resection + chemo.   Alive (5 mo)
  12         43/M            Our case     Stomach and Duodenum       MLP and gastric mocosal thickening    Nuclear and cytoplasmic                                       chemo.               Alive (22 mo)

ALK: Anaplastic lymphoma kinase; FISH: Fluorescence *in situ* hybridization; RT-PCR: Reverse transcription polymerase chain reaction; chemo.: Chemotherapy; auto-SCT: Autologous stem cell transplantation.

The term ''MLP'' was introduced in 1961 by Cornes to describe malignant lymphoma that presented as multiple polypoid tumors, from 2 mm to several centimeters, affecting long segments of the gastrointestinal tract\[[@B21]\]. Histopathologically, these polyps originate from the mantle zone of the lymphoid follicle of the mucosa-associated lymphoid tissue (MALT)\[[@B22]\]. Therefore, the most frequent lymphoma presenting with MLP is MCL\[[@B4],[@B5]\], and it also develops in other B-cell lymphomas, such as MALT lymphoma and follicular lymphoma\[[@B23]\]. Furthermore, T-cell lymphomas seldom show this feature (11%)\[[@B24]\]. Several cases of adult T-cell leukemia/lymphoma presenting with MLP have been reported in Japan, which is an endemic area of human T-cell lymphotropic virus type 1 infection\[[@B25],[@B26]\]. To the best of our knowledge, including ALK-negative, our case is the first observation of ALCL presenting with MLP. However, in contrast to what has been seen in MCL, the MLP presented in this case with, irregular sized-polyps arranged irregularly. In addition, no MLP lesion was found in the large intestine, which is frequently involved in MCL\[[@B27]\]. In our case, MLP lesions could not be detected with PET/CT scans. As we previously reported in a case of MCL\[[@B28]\], it appears that MLP lesions do not infiltrate the deep layer and instead maintain involvement with the surface layer of the gastrointestinal mucosa, even in the case of ALCL. The characteristic endoscopic findings of MCL are not only MLP, but also thickening of gastric mucosal folds has been reported\[[@B5]\]. In our case, thickened folds of the stomach were also seen, and the endoscopic features were thought to be similar to those of MCL.

CONCLUSION
==========

We reported a case of gastroduodenal ALK+ ALCL presenting with MLP. Although there is a limit in considering the macroscopic/endoscopic features of gastrointestinal ALK+ ALCL patients through this very rare case, the morphological features of gastrointestinal ALK+ ALCL may be similar to those of B-cell lymphomas rather than T-cell lymphomas. It is necessary to further accumulate and study the gastrointestinal ALK+ ALCL patients.
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